These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33346515)

  • 1. Racial Differences in Treatment Preferences of Acne Vulgaris: A Cross-Sectional Study.
    Mehta M; Kundu RV
    J Drugs Dermatol; 2020 Dec; 19(12):802. PubMed ID: 33346515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Preferences for Acne Vulgaris Treatment and Barriers to Care: A Survey Study.
    Perche P; Singh R; Feldman S
    J Drugs Dermatol; 2022 Nov; 21(11):1191-1195. PubMed ID: 36342733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of female acne on patterns of health care resource utilization.
    Baldwin HE; Kawata AK; Daniels SR; Wilcox TK; Burk CT; Tanghetti EA
    J Drugs Dermatol; 2015 Feb; 14(2):140-8. PubMed ID: 25689809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over the Counter Products for Acne Treatment and Maintenance in Latin America: A Review of Current Clinical Practice.
    Andriessen A; Rodas Diaz AC; Gameros PC; Macias O; Neves JR; Gonzalez CG
    J Drugs Dermatol; 2021 Mar; 20(3):244-250. PubMed ID: 33683089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability and Efficacy of Clindamycin/Tretinoin versus Adapalene/Benzoyl Peroxide in the Treatment of Acne Vulgaris.
    Aschoff R; Möller S; Haase R; Kuske M
    J Drugs Dermatol; 2021 Mar; 20(3):295-301. PubMed ID: 33683070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acne across Europe: an online survey on perceptions and management of acne.
    Szepietowski JC; Wolkenstein P; Veraldi S; Tennstedt D; Machovcová A; Delarue A
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):463-466. PubMed ID: 29194802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for Using Over-The-Counter Products as Adjunctive Acne Care in Asian Phototypes: Improving Treatment Outcomes and Managing Side Effects.
    Andriessen A; Jiang X; Kulthanan K; Lee CH; Sinclair R; Zhang CF
    J Drugs Dermatol; 2021 Nov; 20(11):1213-1221. PubMed ID: 34784121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choosing the Right Partner: Complementing Prescription Acne Medication With Over-the-Counter Cleansers and Moisturizers.
    Lain E; Andriessen AE
    J Drugs Dermatol; 2020 Nov; 19(11):1069-1075. PubMed ID: 33196748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Race/Ethnicity and Sex With Differences in Health Care Use and Treatment for Acne.
    Barbieri JS; Shin DB; Wang S; Margolis DJ; Takeshita J
    JAMA Dermatol; 2020 Mar; 156(3):312-319. PubMed ID: 32022834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, controlled, evaluator-blinded studies conducted to compare the efficacy and tolerability of 3 over-the-counter acne regimens in subjects with mild or moderate acne.
    Green L; Kircik LH; Gwazdauskas J
    J Drugs Dermatol; 2013 Feb; 12(2):180-5. PubMed ID: 23377391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tazarotene 0.045% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in Adult Males.
    Cook-Bolden FE; Gold MH; Guenin E
    J Drugs Dermatol; 2020 Jan; 19(1):78-85. PubMed ID: 32023013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Reported Outcomes in Acne Patients With Skin of Color Using Adapalene 0.3%-Benzoyl Peroxide 2.5%: A Prospective Real-World Study.
    DuBois J; Ong GCW; Petkar G; Almeida LMC; Chavda R; Kerrouche N; Alexis AF
    J Drugs Dermatol; 2019 Jun; 18(5):514. PubMed ID: 31251543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Many Faces of Pediatric Acne: How to Tailor Nonprescription Acne Treatment and Skincare Using Cleansers and Moisturizers.
    Schachner L; Andriessen A; Benjamin L; Dones M; Kircik L; Pinera-Llano A; Keller L; Hebert A
    J Drugs Dermatol; 2022 Jun; 21(6):602-612. PubMed ID: 35674768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial disparities in the management of acne: evidence from the National Ambulatory Medical Care Survey, 2005-2014.
    Rogers AT; Semenov YR; Kwatra SG; Okoye GA
    J Dermatolog Treat; 2018 May; 29(3):287-289. PubMed ID: 28831837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beliefs, perceptions, and treatment modalities of acne among schoolchildren in Lithuania: a cross-sectional study.
    Karciauskiene J; Valiukeviciene S; Stang A; Gollnick H
    Int J Dermatol; 2015 Mar; 54(3):e70-8. PubMed ID: 25711205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Tazarotene 0.045% Lotion on Quality of Life in Patients With Moderate-to-Severe Acne.
    Kircik LH; Lain E; Gold M; Katz B; Baldwin H; Guenin E; Loncaric A; Pillai R
    J Drugs Dermatol; 2020 Nov; 19(11):1086-1092. PubMed ID: 33196747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in State Medicaid Coverage of Tretinoin for Pigmentary Disorders Compared to Acne Vulgaris.
    Manjaly P; Kamal K; Ly S; Sanchez K; Getachew E; Mostaghimi A; Theodosakis N
    J Drugs Dermatol; 2024 Jun; 23(6):e151-e153. PubMed ID: 38834215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, double-blind study to evaluate the efficacy and safety of 2 treatments in participants with mild to moderate acne vulgaris.
    Draelos ZD; Shalita AR; Thiboutot D; Oresajo C; Yatskayer M; Raab S
    Cutis; 2012 Jun; 89(6):287-93. PubMed ID: 22838094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acne in Algeria: a survey].
    Farhi D; Bouadjar B
    Ann Dermatol Venereol; 2013 May; 140(5):387-9. PubMed ID: 23663714
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of adapalene gel 0.1% vs. tretinoin gel 0.025% in the treatment of acne vulgaris in China.
    Tu P; Li GQ; Zhu XJ; Zheng J; Wong WZ
    J Eur Acad Dermatol Venereol; 2001; 15 Suppl 3():31-6. PubMed ID: 11843231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.